Review of approved pioglitazone combinations for type 2 diabetes

Author： Forst Thomas Hanefeld Markolf Pfüützner Andreas

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.10, 2011-07, pp. : 1571-1584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone: A Review of its Use in Type 2 Diabetes Mellitus

By Waugh John Keating Gillian M. Plosker Greg L. Easthope Stephanie Robinson Dean M.

Drugs, Vol. 66, Iss. 1, 2006-01 ,pp. : 85-109

Adis International

Access to resources Recommend Favorite

Spotlight on pioglitazone in type 2 diabetes

Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Pioglitazone pays dividends in type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pioglitazone takes a proactive stance in type 2 diabetes

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Pioglitazone improves lipid profiles in type 2 diabetes

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite